Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Merck KGaA, Ono Pharmaceutical deal

Ono granted Merck's Merck Serono S.A. division exclusive rights outside of Japan, Korea and Taiwan to

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE